• Advancing Excellence in America's Nursing Homes: Improving Pain Management 
This Implementation Guide provides efficient, consistent, evidence-based approaches to address effective and safe pain management in the nursing home.

• Clinical Process Guideline: PAIN MANAGEMENT

• Minnesota Board of Medical Practice Pain Management Website
See what Minnesota is doing regarding pain management initiatives.

• FDA Issues Second Safety Warning about Fentanyl Patches
The Food and Drug Administration today issued its second safety warning about the fentanyl transdermal system, an adhesive patch that delivers a potent pain medicine through the skin. In July 2005, the agency issued a similar warning to the public and to health care providers, saying that the directions on the product label and on the patient package insert should be followed exactly in order to avoid overdose. FDA has continued to receive reports of deaths and life-threatening side effects after doctors have inappropriately prescribed the patch or patients have incorrectly used it.

• Responsible Opioid Prescribing: A Physician's Guide
In collaboration with author Scott Fishman, M.D., medical writer Stephen Braun and publisher Waterford Life Sciences, the FSMB Research and Education Foundation has developed a book on responsible opioid prescribing based on the FSMB Model Policy for Prescribing Controlled Substances for the Treatment of Pain. The Foundation plans to distribute the book through individual state medical boards to the approximately 750,000 licensed physicians in the United States. Working in collaboration with the author, writer and publisher, the Foundation will distribute print copies of the book to physicians on a state-by-state basis, as funds are raised. The handbooks can be customized to include state-specific policies, rules and regulations, and statutes.

• DEA Policy Statement on Dispensing Controlled Substances for the Treatment of Pain
U.S. Department of Justice, Drug Enforcement Administration, policy statement on the dispensing controlled substances for the treatment of pain, dated August 28, 2006.

• Model Guidelines for the Use of Complementary and Alternative Therapies in Medical Practice 
Approved by the House of Delegates of the Federation of State Medical Boards of the United States, Inc., as policy April 2002.

• The Alliance of State Pain Initiatives (ASPI)
A network of state-based Pain Initiative organizations that work to remove the barriers that impede pain relief through education, advocacy and institutional improvement.

• Federation of State Medical Boards of the United States, Inc. - Model Policy for the Use of Controlled Substances for the Treatment of Pain (May 2004) 
The Model Policy for the Use of Controlled Substances for the Treatment of Pain was developed in collaboration with pain experts around the country to provide guidance to state medical boards in developing pain policies and regulations.

• Nursing Guidelines for the Use of Controlled Substances for the Treatment of Pain 

• Pharmacy Guidelines for the Use of Controlled Substances for the Treatment of Pain 

• Overview-MI Guidelines for the Use of Controlled Substances for the Treatment of Pain 

• Medicine and Osteopathic Medicine Guidelines for the Use of Controlled Substances for the Treatment of Pain